#United States #Chicago #Research Funding #American Lung Association #Lung Health

American Lung Association's Commitment to Lung Health

The American Lung Association (ALA) has announced a groundbreaking initiative, investing $21 million into research aimed at addressing significant challenges in lung health. This initiative is part of ALA's ongoing commitment to advancing knowledge in tackling serious respiratory diseases and improving air quality for all.

The funding is essential for tackling prevailing issues such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD), all of which affect millions of Americans. Over the past decade, the ALA has channeled a total of $193 million into research and scientific endeavors, helping to establish a robust infrastructure that supports innovative research in the field.

Harold Wimmer, the organization’s President and CEO, stated, “The American Lung Association is the only voluntary health organization focused entirely on the multitude of diseases affecting lung health. Investing in research is vital for advancing prevention, diagnosis, and treatment of these diseases.” This sentiment underscores the organization's essential role in championing lung health.

Current Lung Health Landscape

Approximately 35 million Americans are grappling with chronic lung diseases, such as asthma and COPD. The year 2023 is expected to witness nearly 226,650 new cases of lung cancer, highlighting an urgent need for innovative research. Furthermore, respiratory ailments can flare up acutely; it is estimated that there are over 44 million cases of acute respiratory diseases, which include pneumonia, influenza, and COVID-19, occurring annually.

Air quality remains a significant concern, with 152 million people in the U.S. living in areas that have failed to meet safe air pollution standards. These statistics indicate that countless individuals are inhaling unhealthy air that could severely impact their lung health.

Funding Overview

The recent investment of $21 million specifically facilitates over 120 projects under the ALA's Awards and Grants Program, which spans various crucial research categories. The categories focus on numerous aspects of lung health, including allergic respiratory diseases, indoor air quality, lung cancer, and emerging respiratory pathogens, among others.

Recent grantees have received funding for significant projects aimed at redefining treatment protocols and understanding underlying lung disease mechanisms. For instance, Dr. James Kim from The University of Texas Southwestern Medical Center is examining how small cell lung cancer spreads to the brain with his project titled, “Epithelial to Neuronal Transition as a Driver of SCLC Brain Metastasis.” His research holds the promise of identifying new therapeutic targets that could enhance treatment plans for patients suffering from this aggressive form of cancer.

Dr. Mary Berlik Rice from Harvard T.H. Chan School of Public Health is also breaking ground with her project, “Purifying Indoor Air of Biological and Chemical Pollutants to Enhance Respiratory Health in Eosinophilic COPD.” This work looks at the effects of cleaner indoor air on patients with COPD, potentially leading to better health outcomes through improved air quality.

Moreover, innovation in lung health is being spurred by Dr. Filiz Korkmaz at The University of Iowa, whose study on “Mechanisms of Lung Repair through LOX-1+ Neutrophils and B Cell Crosstalk” investigates how immune cells can help minimize lung damage during infections, paving the way for novel treatment avenues.

Future Directions

Each project funded by the ALA undergoes rigorous peer-review processes to ensure that the research is scientifically sound and carries the potential for genuine public health impact. Additionally, the ALA supports the Airways Clinical Research Centers Network, which represents the largest nonprofit network dedicated to asthma and COPD research in the nation.

With the window for 2027–2028 research awards and grants now open, the American Lung Association is poised to continue its vital mission in lung health research. Information regarding funding opportunities is accessible at Lung.org/awards.

About American Lung Association

The American Lung Association has long been recognized as the leading entity devoted to respiratory health. Focusing on strategic imperatives such as defeating lung cancer, ensuring clean air, and establishing a tobacco-free future, it has solidified itself as a pillar in health advocacy. For support or information about their initiatives, individuals are encouraged to reach out through Lung.org or call 1-800-LUNGUSA (1-800-586-4872).

This investment in research exemplifies the ALA's commitment to elevating lung health and addressing the challenges facing millions of Americans today.